Mark A. Winters - Concepedia

Author

Mark A. Winters

Also Known As

David L. Shugarts, M A Winters, M Winters, M. A. Winters, M. WINTERS, M. Winters, M.A. Winters, MARK A. WINTERS, Mackenzie Winters, Mark A Winters

134

Publications

Citations

H-Index

111

Concepts

All Affiliations

Stanford University Stanford Medicine VA Palo Alto Health Care System AIDS United National Institutes of Health

About

Mark A. Winters is an author at Stanford University specializing in medicine, hiv, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	48	3.4K
2	Natural Sciences	7	7	291
3	Public Health	5	5	199
4	Engineering	4	4	771
5	Health Sciences	3	3	224

Mark A. Winters

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
siRNA Delivery into Human T Cells and Primary Cells with Carbon‐Nanotube Transporters Zhuang Liu, Mark A. Winters, Mark Holodniy, Angewandte Chemie International Edition NanotherapeuticsEngineeringImmunologyGene DeliveryBiomedical Engineering	2007	661
A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy John D. Baxter, Douglas L. Mayers, Deborah Wentworth, AIDS	2000	502
Frequency of Class I HLA-Restricted Anti-HIV CD8+ T Cells in Individuals Receiving Highly Active Antiretroviral Therapy (HAART) Clive M. Gray, Jody Lawrence, Jonathan Schapiro, The Journal of Immunology	1999	268
Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells Ronald T. Mitsuyasu, Thomas C. Merigan, Andrew Carr, Nature Medicine Gene Therapy TrialMedicineHuman RetrovirusImmunologyAnti-hiv Ribozyme	2009	263
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial Christopher Koh, Laëtitia Canini, Harel Dahari, The Lancet Infectious Diseases Hepatitis DHepatologyViral HepatitisPharmacologyHepatitis B	2015	258
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy Astrid K. N. Iversen, Robert W. Shafer, K Wehrly, Journal of Virology	1996	247
A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors. Mark A. Winters, Kristi L. Coolley, Yvette A. Girard, Journal of Clinical Investigation 6-Basepair InsertImmunologyMolecular BiologyPharmacotherapyAntiviral Drug	1998	225
A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution Robert J. Gifford, Aris Katzourakis, Michael Tristem, Proceedings of the National Academy of Sciences	2008	209
Combination Therapy with Zidovudine and Didanosine Selects for Drug-Resistant Human Immunodeficiency Virus Type 1 Strains with Unique Patterns of pol Gene Mutations Robert W. Shafer, Michael J. Kozal, Mark A. Winters, The Journal of Infectious Diseases	1994	208
Rapid method for epidemiological evaluation of gram-positive cocci by field inversion gel electrophoresis Richard V. Goering, Mark A. Winters Journal of Clinical Microbiology Pathogen DetectionDna AnalysisPathologyRapid MethodAgarose Blocks	1992	195

Page 1